The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1626
June 14, 2021
View Complete Issue         Table of Contents 2019 
Drugs for Chronic Heart Failure
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drugs for Chronic Heart Failure
June 14, 2021 (Issue: 1626)
Among patients with chronic heart failure, those with a left ventricular ejection fraction (LVEF) ≤40% are considered to have heart failure with reduced ejection fraction (HFrEF). Patients with a LVEF ≥50% are considered to have heart failure...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Chronic Heart Failure
Article code: 1626a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.